Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’. The location where diagnostic tests are delivered i.e. in the laboratories or at the point-of-care (POC) also encompasses the definition for ‘diagnostic testing of STDs’. The Medicines and Healthcare Products Regulatory Agency (MHRA) defines POC ... Read more

The global diagnostic testing of STDs market is estimated to be valued at US$10.4 billion in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period of 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The diagnostic testing of STDs market includes a range of tests and diagnostic tools used to identify sexually transmitted diseases. These tests play a crucial role in early detection and ... Read more

Sexually transmitted diseases (STDs) such as gonorrhea, chlamydia, syphilis, and trichomoniasis are very common and require diagnostic testing for their treatment. STD diagnostic tests involve testing of samples such as blood, urine, swab from external genitals, rectum, or mouth to detect the presence of disease-causing pathogens. Conventional STD diagnostic techniques include laboratory tests such as nucleic acid amplification tests (NAAT), enzyme immunoassays (EIA), and rapid point-of-care ... Read more

Diagnostic testing of sexually transmitted diseases (STDs) involves laboratory tests to detect the presence of an infection. These tests are known as sexually transmitted infection diagnostic tests (STD Tests) or sexually transmitted disease diagnostic tests and are carried out on various clinical specimens such as blood, urine, swabs from external genitalia, throat, rectum, or cervicovaginal depending on the infection being tested for. Diagnostic testing helps in providing appropriate ... Read more